All sponsors

AskBio Inc

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-20
ACTIVE TRIALS5
PHASE 3 / 2-30
RECRUITING1
READOUTS ≤12 MONTHS0
Open AskBio Inc on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
GenePHIT
NCT05598333
P2Active, not recruitingCongestive Heart Failure1502026-10-31 (-37 mo)
PIA
NCT07215403
P2Not yet recruitingPARKINSON DISEASE (Disorder)182028-04-30 (+4 mo)
REGENERATE-PD
NCT06285643
P2Active, not recruitingParkinson Disease592028-08-31 (+9 mo)
AB-1009 (GAA Gene)
NCT07282847
P1/2RecruitingPompe Disease (Late-onset); Pompe Disease Late-Onset122028-09
AB-1003 dose level 1
NCT05230459
P1/2Active, not recruitingLimb Girdle Muscular Dystrophy; Limb-Girdle Muscular Dystrophy Type 292028-12